Nordic and Unigene formed a JV, NU-Co GmbH, to develop one or more of Unigene's calcitonin analogs to treat Type II diabetes

Nordic Bioscience A/S

Denmark / Medical Devices and Diagnostics

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Unigene Laboratories Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$97.5m on 10/07/2011 [market cap]

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced